| Product NDC: | 0378-1400 |
| Proprietary Name: | Acebutolol Hydrochloride |
| Non Proprietary Name: | acebutolol hydrochloride |
| Active Ingredient(s): | 400 mg/1 & nbsp; acebutolol hydrochloride |
| Administration Route(s): | ORAL |
| Dosage Form(s): | CAPSULE |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 0378-1400 |
| Labeler Name: | Mylan Pharmaceuticals Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA074288 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20120925 |
| Package NDC: | 0378-1400-01 |
| Package Description: | 100 CAPSULE in 1 BOTTLE (0378-1400-01) |
| NDC Code | 0378-1400-01 |
| Proprietary Name | Acebutolol Hydrochloride |
| Package Description | 100 CAPSULE in 1 BOTTLE (0378-1400-01) |
| Product NDC | 0378-1400 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | acebutolol hydrochloride |
| Dosage Form Name | CAPSULE |
| Route Name | ORAL |
| Start Marketing Date | 20120925 |
| Marketing Category Name | ANDA |
| Labeler Name | Mylan Pharmaceuticals Inc. |
| Substance Name | ACEBUTOLOL HYDROCHLORIDE |
| Strength Number | 400 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC] |